source
- STAT+: Helus’ psychedelic drug improved depression in study but faces safety questionsA psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious adverse events reported.
- Physician burnout persists as hospitals push self-care instead of systemic fixesIn a new STAT+ column, former ENT surgeon Frances Mei Hardin reflects on the growing crisis of physician burnout and the limited impact of hospital‑mandated wellness programs. Hardin shares a pers…